A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms

ABSTRACT Patients with neuropathic pain syndromes are heterogeneous. They present with a variety of sensory symptoms and pain qualities. The knowledge of these data and etiology‐specific differences is important to optimize clinical trial design and to develop more effective drugs. This investigation uses epidemiological and clinical data on the symptomatology of 2100 patients with painful diabetic neuropathy (DPN) and postherpetic neuralgia (PHN) from a cross‐sectional survey (painDETECT) to (1) describe characteristic epidemiological differences, (2) analyse typical patterns of sensory symptoms in both cohorts and (3) determine whether questionnaires can capture these characteristics. PHN patients suffer more often from clinically relevant sensory disturbances although the average pain intensity is only marginally higher. This difference is particularly obvious with dynamic mechanical allodynia which is present in half of the PHN patients and in 18% of the DPN patients. Thermal hyperalgesia occurs twice as often in PHN. Numbness is described more often in DPN. Age has no influence on sensory symptoms in both entities. A hierarchical cluster analysis revealed five distinct subgroups of patients showing a characteristic sensory profile, a typical constellation and combination of neuropathic symptoms. All subgroups occur in relevant numbers in both entities but the frequencies differ between PHN and DPN. Since sensory symptoms likely translate into pain‐generating mechanisms enrichment for potential treatment responders might be possible in clinical trials by assessing the sensory profiles. Patient‐Reported Outcomes can be used to obtain a precise sensory characterization of each patient.

[1]  Ralf Baron,et al.  Mechanisms of Disease: neuropathic pain—a clinical perspective , 2006, Nature Clinical Practice Neurology.

[2]  N. Leidy,et al.  Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[3]  M. Rowbotham,et al.  The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia. , 1996, Brain : a journal of neurology.

[4]  T. Toelle,et al.  The burden of neuropathic pain: results from a cross‐sectional survey , 2006, European journal of pain.

[5]  D. McKemy,et al.  Identification of a cold receptor reveals a general role for TRP channels in thermosensation , 2002, Nature.

[6]  J. Dostrovsky,et al.  Neuropathic pain , 2008, Neurology.

[7]  T. Tölle,et al.  Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns. , 2006, Journal of diabetes and its complications.

[8]  G. Wasner,et al.  Postherpetic neuralgia: epidemiology, pathophysiology and management , 2007, Expert review of neurotherapeutics.

[9]  C. Woolf,et al.  Neuropathic pain: aetiology, symptoms, mechanisms, and management , 1999, The Lancet.

[10]  J. Gu,et al.  TRPM8 Mechanism of Cold Allodynia after Chronic Nerve Injury , 2007, The Journal of Neuroscience.

[11]  R. Baron,et al.  Translation of symptoms and signs into mechanisms in neuropathic pain , 2003, Pain.

[12]  J. Unützer,et al.  Monitoring Depression Treatment Outcomes With the Patient Health Questionnaire-9 , 2004, Medical care.

[13]  R. Baron,et al.  painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain , 2006, Current medical research and opinion.

[14]  B. Yawn,et al.  A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. , 2007, Mayo Clinic proceedings.

[15]  R. Dworkin,et al.  Clinical trial outcome in neuropathic pain , 2008, Neurology.

[16]  G. Wasner,et al.  Herpes Zoster and Postherpetic Neuralgia , 2008, Drugs & aging.

[17]  T. Larson,et al.  Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. , 2000, Diabetes care.

[18]  J. Farrar,et al.  Pharmacologic management of neuropathic pain: Evidence-based recommendations , 2007, PAIN.

[19]  A. Vinik,et al.  Lamotrigine for treatment of pain associated with diabetic neuropathy: Results of two randomized, double-blind, placebo-controlled studies , 2007, Pain.

[20]  R. Hays,et al.  Psychometric properties of the Medical Outcomes Study Sleep measure. , 2005, Sleep medicine.

[21]  M. Bennett,et al.  Using screening tools to identify neuropathic pain , 2007, PAIN.

[22]  R. Lipton,et al.  Towards a mechanism-based classification of pain? , 1998, Pain.

[23]  G. Cruccu,et al.  EFNS guidelines on neuropathic pain assessment , 2004, European journal of neurology.

[24]  T. Kohlmann,et al.  Paper versus electronic rating scales for pain assessment: a prospective, randomised, cross-over validation study with 200 chronic pain patients , 2008, Current medical research and opinion.